Clinical Trials Logo

Clinical Trial Summary

Delayed wound healing leads to increased risk for infection, and thus increased risk for morbidity and mortality. Skin oxygen delivery and peripheral blood flow predict wound healing. The investigators will conduct a double-masked, placebo-controlled cross-over clinical pilot trial in order to evaluate the effects of a topical, homeopathic/herbal salve (Original Healing Salve, Puremedy, Inc.) on skin oxygenation and peripheral blood flow.


Clinical Trial Description

Delayed wound healing leads to increased risk for infection, and thus increased risk for morbidity and mortality. Skin oxygen delivery and peripheral blood flow predict wound healing. In order to evaluate the effects of a topical, homeopathic/herbal salve (Original Healing Salve, Puremedy, Inc.) on skin oxygenation and peripheral blood flow, the investigators will conduct a double-masked, placebo-controlled cross-over clinical pilot trial with randomized testing order to evaluate the effects of the salve on cutaneous oxygen saturation (TcPO2) and ankle-to-brachial pressure index (ABPI). The investigators will recruit thirty-two participants in two cohorts to participate, one with and one without type 2 diabetes, who are otherwise generally healthy without active wounds, ulcers or skin rashes. Both TcPO2 and ABPI will be measured before and after the application of both the homeopathic/herbal salve ("active"), and before and after the application of the inert salve base ("placebo"). Analyses will compare pre/post changes in TcPO2 and ABPI before and after application of the active salve within the same visit, and also compare the changes from the active salve to the before and after changes in TcPO2 and ABPI measured from the placebo salve. If the Original Healing Salve improves cutaneous oxygenation and/or ABPI, future research may evaluate the formula specifically for wound healing and antimicrobial effects. Thus the proposed research is a pilot study targeting mechanistic outcomes, which predict potential clinical efficacy. The proposed research is significant, as lower cost, more effective treatments are needed to improve wound healing and reduce the morbidity associated with the complications of delayed wound healing. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02394366
Study type Interventional
Source National University of Natural Medicine
Contact
Status Completed
Phase Phase 2
Start date March 2015
Completion date October 2015

See also
  Status Clinical Trial Phase
Terminated NCT04366310 - Capillary Refill Index With Rewarming
Completed NCT03078712 - Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study N/A
Completed NCT04040478 - Transcutaneous Monitoring of Oxygen and Carbon Dioxide in Surgical Patients
Recruiting NCT03762005 - Peripheral Perfusion Versus Lactate Targeted Fluid Resuscitation in Septic Shock N/A
Completed NCT02771002 - Assessment of Peripheral Perfusion in the Critically Ill Patient N/A
Completed NCT04538612 - DiCART TM Device for Capillary Refill Time Measurement N/A
Completed NCT03845361 - Radial Artery Cannulation and Perfusion Index N/A
Completed NCT04688203 - Effects Magnesium Sulfate and Labetalol Infusion on Peripheral Perfusion and Pain in Nasal Surgeries Phase 1/Phase 2
Recruiting NCT04043481 - Modified Allen's Test and Peripheral Perfusion Index
Completed NCT03395483 - Peripheral and Mesenteric Perfusion in Elective Surgical Patients